Lv1
40 积分 2023-04-13 加入
[Expert consensus on clinical application of next-generation sequencing in advanced breast cancer (2024 edition)]
8天前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
9天前
已完结
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
1个月前
已完结
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC
1个月前
已完结
Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis
1个月前
已完结
Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC
1个月前
已完结
[China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)]
3个月前
已完结
Diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small Cell Lung Cancer in China
4个月前
已完结
Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer
4个月前
已关闭
Real-world data of EGFR mutation testing in Chinese non-small cell carcinoma: Low tumor cell number and tumor cellularity can be accepted
4个月前
已完结
皖公网安备34019202002308
